Study of PFLotus for persistent atrial fibrillation
Part of Heart & circulation clinical trials.
This study tests a new device called PFLotus for people with persistent atrial fibrillation (AF), a type of irregular heartbeat. The goal is to see if it can help restore a normal heart rhythm in people who haven't gotten better with medicine.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 75 years old.
- You have been diagnosed with persistent atrial fibrillation (AF) that lasts longer than 7 days and causes symptoms.
- You have tried at least one heart rhythm medicine and it didn't work well or caused side effects.
- You have not had a previous catheter ablation or heart surgery for AF.
- You do not have other serious health problems like heart failure, blood clotting issues, or cancer.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new way to treat persistent atrial fibrillation (a type of irregular heartbeat that lasts more than 7 days) using a specialized mapping system. It aims to help people who have not gotten relief from medications or cannot tolerate them.
This trial tests a newer type of ablation (pulsed field ablation) for people with persistent atrial fibrillation who have already had one ablation. The goal is to see if it can fix the heart rhythm problem again.
This trial tests a new type of ablation (pulsed-field) to treat persistent atrial fibrillation (AFib) that lasts more than 7 days. You may qualify if you have symptoms and haven't had other heart ablation procedures except for one specific type.
This trial tests a new way to deliver energy (FARAPULSE PFA system) to treat atrial fibrillation (AF), a type of irregular heartbeat. It aims to see if these new waveforms can safely and effectively stop AF symptoms and improve quality of life.
This trial tests a newer ablation procedure (PulseSelect) to treat atrial fibrillation—a common heart rhythm problem. The goal is to see if this optimized workflow helps patients have fewer symptoms and better outcomes.
This trial tests a new tool called FARAFLEX that uses pulsed electrical energy to treat atrial fibrillation (an irregular heart rhythm). The goal is to see if this method can safely stop AF symptoms in people whose medications haven't worked.
Hear when a new Persistent Atrial Fibrillation trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.